ZYUS Life Sciences Corporation
ZLSCF
$0.00
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -24.12M | -24.36M | -24.68M | -24.39M | -26.86M |
| Total Depreciation and Amortization | 2.06M | 2.07M | 2.11M | 2.16M | 2.19M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.41M | 14.31M | 14.00M | 13.78M | 14.95M |
| Change in Net Operating Assets | -1.36M | -281.60K | 224.80K | -86.90K | 2.95M |
| Cash from Operations | -9.00M | -8.27M | -8.34M | -8.54M | -6.77M |
| Capital Expenditure | -7.20K | -8.80K | -8.80K | -34.00K | -174.40K |
| Sale of Property, Plant, and Equipment | 18.10K | 18.10K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.34M | 1.34M | 2.50M | 2.71M | 1.33M |
| Cash from Investing | 1.35M | 1.35M | 2.49M | 2.68M | 1.15M |
| Total Debt Issued | 11.04M | 8.96M | 7.45M | 5.70M | 700.00K |
| Total Debt Repaid | -314.00K | -2.86M | -2.86M | -3.04M | -3.36M |
| Issuance of Common Stock | 0.00 | 3.31M | 3.31M | 3.31M | 3.31M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 7.68M | 6.73M | 5.64M | 4.28M | 476.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 29.30K | -186.20K | -205.30K | -1.58M | -5.14M |